Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Occup Environ Med ; 64(6): 373-9, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17182639

RESUMO

BACKGROUND: Particulate air pollution has been associated with several adverse cardiovascular health outcomes, and people with diabetes may be especially vulnerable. One potential pathway is inflammation and endothelial dysfunction-processes in which cell adhesion molecules and inflammatory markers play important roles. AIM: To examine whether plasma levels of soluble intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1) and von Willebrand factor (vWF) were associated with particle exposure in 92 Boston area residents with type 2 diabetes. METHODS: Daily average ambient levels of air pollution (fine particles (PM2.5), black carbon (BC) and sulphates) were measured approximately 500 m from the patient examination site and evaluated for associations with ICAM-1, VCAM-1 and vWF. Linear regressions were fit to plasma levels of ICAM-1, VCAM-1 and vWF, with the particulate pollutant index, apparent temperature, season, age, race, sex, glycosylated haemoglobin, cholesterol, smoking history and body mass index as predictors. RESULTS: Air pollutant exposure measures showed consistently positive point estimates of association with the inflammatory markers. Among participants not taking statins and those with a history of smoking, associations between PM(2.5), BC and VCAM-1 were particularly strong. CONCLUSIONS: These results corroborate evidence suggesting that inflammatory mechanisms may explain the increased risk of air pollution-associated cardiovascular events among those with diabetes.


Assuntos
Diabetes Mellitus Tipo 2/sangue , Angiopatias Diabéticas/sangue , Material Particulado/toxicidade , Vasculite/induzido quimicamente , Adulto , Boston/epidemiologia , Estudos Transversais , Diabetes Mellitus Tipo 2/epidemiologia , Angiopatias Diabéticas/induzido quimicamente , Angiopatias Diabéticas/epidemiologia , Suscetibilidade a Doenças/sangue , Suscetibilidade a Doenças/induzido quimicamente , Exposição Ambiental/efeitos adversos , Exposição Ambiental/análise , Feminino , Humanos , Molécula 1 de Adesão Intercelular/metabolismo , Masculino , Molécula 1 de Adesão de Célula Vascular/metabolismo , Vasculite/sangue , Vasculite/epidemiologia , Fator de von Willebrand/metabolismo
2.
Endocr Pract ; 6(5): 351-6, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-11141584

RESUMO

OBJECTIVE: To assess how physicians who have ordered bone densitometry studies respond to abnormal results. METHODS: We conducted a retrospective review of cases from physicians affiliated with a community teaching hospital. The study sample consisted of 142 female patients with abnormal bone mineral density (BMD) who had been referred by 50 physicians (internists or gynecologists). A questionnaire was completed for each patient, providing data about further investigations, treatment interventions, and frequency of referral to a specialist in bone diseases. RESULTS: Of the patients diagnosed with osteoporosis on the basis of BMD studies, 20.4% had no further investigations, and 27.8% underwent only mammography. Of all the patients with osteoporosis, 10.6% received no therapy (calcium and vitamin D excluded). The majority of all patients (71.8%) received a combination of calcium and vitamin D. The most common treatment modality was hormone replacement therapy. The second most common treatment strategy was bisphosphonates. The percentage of all referrals to specialists in metabolic bone diseases was low--11.3% in the patients of internists and 14.5% in the patients of gynecologists. CONCLUSION: In this study, the information provided by bone densitometry did not affect management in a substantial percentage of patients. A considerable percentage of patients underwent no further investigations to rule out secondary causes of osteoporosis.


Assuntos
Osso e Ossos/diagnóstico por imagem , Densitometria , Osteoporose Pós-Menopausa/diagnóstico por imagem , Osteoporose Pós-Menopausa/terapia , Médicos , Idoso , Cálcio da Dieta/uso terapêutico , Difosfonatos/uso terapêutico , Terapia de Reposição de Estrogênios , Feminino , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Pessoa de Meia-Idade , Radiografia , Estudos Retrospectivos , Inquéritos e Questionários , Vitamina D/uso terapêutico
3.
Clin Podiatr Med Surg ; 15(1): 85-93, 1998 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-9463769

RESUMO

Wound healing is defective in patients with diabetes, which may be attributed to many factors. Our data indicate that impairment of the microcirculation is a major factor. Although the exact causes of microvascular impairment are not known, dysfunction of the endothelium has emerged over the last decade as the prominent abnormality related to vascular disease in diabetes. Further studies are required to clarify the causes of endothelial dysfunction and identify potential therapeutic interventions in the future.


Assuntos
Pé Diabético/fisiopatologia , Endotélio Vascular/fisiologia , Pé/irrigação sanguínea , Cicatrização , Humanos , Inflamação , Microcirculação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...